$KVAC
Keen Vision Acquisition Corp Stock $kvac

$kvac Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086916 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$168.1K	$305.7K
YoY Change
Operating Profit
YoY Change
Interest Expense	$1.933M	$20.00
YoY Change
% of Operating Profit
Other Income/Expense, Net		$19.00
YoY Change		850.0%
Pretax Income	$1.765M	-$305.7K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$1.765M	-$305.7K
YoY Change		140124.31%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.09	-$0.02
COMMON SHARES
Basic Shares Outstanding	19.37M shares	19.37M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$631.8K	$735.4K
YoY Change
Cash & Equivalents	$631.8K	$735.4K	$77.71K
Short-Term Investments
Other Short-Term Assets	$233.9K	$314.3K
YoY Change
Inventory
Prepaid Expenses	$233.9K	$314.3K	$2.598K
Receivables
Other Receivables
Total Short-Term Assets	$865.6K	$1.050M	$80.31K
YoY Change	977.89%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$154.8M	$152.8M
YoY Change
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$154.8M	$152.8M	$114.5K
YoY Change	135116.86%
TOTAL ASSETS
Total Short-Term Assets	$865.6K	$1.050M	$80.31K
Total Long-Term Assets	$154.8M	$152.8M	$114.5K
Total Assets	$155.7M	$153.8M	$194.8K
YoY Change	79819.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$4.000K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.00K	$30.00K	$173.6K
YoY Change	-91.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.990M	$2.990M
YoY Change
Total Long-Term Liabilities	$2.990M	$2.990M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.00K	$30.00K	$173.6K
Total Long-Term Liabilities	$2.990M	$2.990M
Total Liabilities	$3.004M	$3.020M	$173.6K
YoY Change	1630.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.660M	-$3.367M	-$3.766K
YoY Change	97085.29%
Common Stock	$442.00	$442.00	$374.00
YoY Change	18.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$152.7M	-$1.970M	$21.23K
YoY Change
Total Liabilities & Shareholders Equity	$155.7M	$153.8M	$194.8K
YoY Change	79819.58%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$1.765M	-$305.7K
YoY Change		140124.31%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$83.66K	-$619.5K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$151.4M
YoY Change
Cash From Investing Activities	$0.00	-$151.4M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.00K	152.7M
YoY Change
NET CHANGE
Cash From Operating Activities	-83.66K	-619.5K
Cash From Investing Activities	0.000	-151.4M
Cash From Financing Activities	-20.00K	152.7M
Net Change In Cash	-103.7K	152.1M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$83.66K	-$619.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41753
	dei	Entity Registrant Name EntityRegistrantName	KEEN VISION ACQUISITION CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
	dei	Entity Address Address Line1 EntityAddressAddressLine1	37 Greenbriar Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Summit
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07901
	dei	City Area Code CityAreaCode	(203)
	dei	Local Phone Number LocalPhoneNumber	609-1394
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19366075	shares
CY2023Q3	us-gaap	Cash Cash	735412	usd
CY2022Q4	us-gaap	Cash Cash	77709	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	314275	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2598	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1049687	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	80307	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	114500	usd
CY2023Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	152764949	usd
CY2023Q3	us-gaap	Assets Assets	153814636	usd
CY2022Q4	us-gaap	Assets Assets	194807	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	30000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	173573	usd
CY2023Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2990000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	3020000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	173573	usd
CY2023Q3	kvac	Common Stock Subject To Conversion Shares CommonStockSubjectToConversionShares	14950000	shares
CY2022Q4	kvac	Common Stock Subject To Conversion Shares CommonStockSubjectToConversionShares	14950000	shares
CY2023Q3	kvac	Common Stock Subject To Conversion Per Share CommonStockSubjectToConversionPerShare	10.22
CY2022Q4	kvac	Common Stock Subject To Conversion Per Share CommonStockSubjectToConversionPerShare	10.22
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	152764949	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	24626	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1396198	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3366953	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3766	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1970313	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21234	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	153814636	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	194807	usd
CY2023Q3	us-gaap	Direct Operating Costs DirectOperatingCosts	305708	usd
CY2022Q3	us-gaap	Direct Operating Costs DirectOperatingCosts	220	usd
	us-gaap	Direct Operating Costs DirectOperatingCosts	310586	usd
	us-gaap	Direct Operating Costs DirectOperatingCosts	397	usd
CY2023Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	18	usd
CY2022Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	19	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	4	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-305689	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-218	usd
	us-gaap	Net Income Loss NetIncomeLoss	-310566	usd
	us-gaap	Net Income Loss NetIncomeLoss	-393	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Hybrid Instrument Net UnrealizedGainLossOnHybridInstrumentNet	1396198	usd
	us-gaap	Unrealized Gain Loss On Hybrid Instrument Net UnrealizedGainLossOnHybridInstrumentNet	1396198	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1090509	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-218	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1085632	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-393	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4032	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	17202	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-845	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	16357	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	142902020	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6785750	usd
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	147855258	usd
CY2023Q3	kvac	Allocation Of Offering Costs To Common Stock Subject To Redemption AllocationOfOfferingCostsToCommonStockSubjectToRedemption	6525391	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-11435082	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-305689	usd
CY2023Q3	kvac	Unrealized Gain On Available Held For Sale Securities UnrealizedGainOnAvailableHeldForSaleSecurities	1396198	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1970313	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21927	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-176	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	21751	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	21752	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-218	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	21534	usd
	us-gaap	Net Income Loss NetIncomeLoss	-310566	usd
	us-gaap	Net Income Loss NetIncomeLoss	-393	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	1	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	311677	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-622244	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-393	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust		usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	151368750	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-151368750	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	264049	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	293122	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	60000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	149500000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6785750	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3607980	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	47500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	152648697	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12520	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	657703	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12913	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77709	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24924	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	735412	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12031	usd
	kvac	Initial Classification Of Common Stock Subject To Possible Redemption InitialClassificationOfCommonStockSubjectToPossibleRedemption	147853763	usd
	kvac	Allocation Of Offering Costs To Common Stock Subject To Possible Redemption AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption	6525391	usd
	kvac	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	11435082	usd
	kvac	Accrued Underwriting Compensation AccruedUnderwritingCompensation	2990000	usd
	kvac	Public Warrant Description PublicWarrantDescription	Each Public Unit consists of one ordinary share and one redeemable warrant (“Public Warrant”) to purchase one ordinary share at an exercise price of $11.50 per share.
	kvac	Private Warrant Description PrivateWarrantDescription	Each Private Placement Unit consists of one ordinary share and one redeemable warrant (“Private Warrant”) to purchase one ordinary share at an exercise price of $11.50 per whole share.
	us-gaap	Sale Leaseback Transaction Transaction Costs Financing Activities SaleLeasebackTransactionTransactionCostsFinancingActivities	6597980	usd
	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	2990000	usd
CY2023Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	2990000	usd
CY2023Q3	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts	617980	usd
CY2023Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	1593452	usd
CY2023Q3	us-gaap	Cash Cash	151368750	usd
CY2023Q3	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	151368750	usd
	kvac	Public Price Unit PublicPriceUnit	10.125
CY2023Q3	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Debt Securities FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentDebtSecurities	0.80	pure
CY2023Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5000001	usd
	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.15	pure
	kvac	Public Price Per Share PublicPricePerShare	10.125
CY2023Q3	us-gaap	Cash Reserve Deposit Required And Made CashReserveDepositRequiredAndMade	1495000	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.1
	kvac	Outstanding Public Shares OutstandingPublicShares	1	pure
	us-gaap	Other Expenses OtherExpenses	50000	usd
	kvac	Working Capital Surplus WorkingCapitalSurplus	1019687	usd
	us-gaap	Net Income Loss NetIncomeLoss	-310566	usd
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Use of estimates</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2022Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	218	usd
CY2023Q3	kvac	Ordinary Share Subject To Possible Redemption OrdinaryShareSubjectToPossibleRedemption	14950000	shares
CY2022Q4	kvac	Ordinary Share Subject To Possible Redemption OrdinaryShareSubjectToPossibleRedemption	0	shares
CY2023Q3	kvac	Purchase Of Aggregate Shares PurchaseOfAggregateShares	15628575	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-310566	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-393	usd
	kvac	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	11435082	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	11745648	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	393	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-305689	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-218	usd
CY2023Q3	kvac	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	11435082	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	11740771	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Concentration of credit risk</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	14950000	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	3737500	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	487500	shares
CY2021Q3	srt	Financing Receivable Allowance For Credit Loss To Outstanding Percent FinancingReceivableAllowanceForCreditLossToOutstandingPercent	0.20	pure
CY2021Q3	kvac	Aggregate Purchase Price Amount AggregatePurchasePriceAmount	25000	usd
	us-gaap	Sponsor Fees SponsorFees	0	usd
CY2022	us-gaap	Sponsor Fees SponsorFees	173573	usd
	us-gaap	Affiliate Costs AffiliateCosts	10000	usd
	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	30000	usd
CY2022	us-gaap	Investment Company Shareholder Service Fee Expense InvestmentCompanyShareholderServiceFeeExpense	0	usd
CY2023Q3	us-gaap	Interest Costs Incurred InterestCostsIncurred	30000	usd
CY2022Q3	us-gaap	Interest Costs Incurred InterestCostsIncurred	0	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	30000	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	0	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4416075	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4416075	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3737500	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3737500	shares
	kvac	Percentage Of Issued And Outstanding Shares PercentageOfIssuedAndOutstandingShares	0.20	pure
CY2023Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.01
	kvac	Exceeds Price Per Share ExceedsPricePerShare	16.5
	kvac	Effective Issue Price Per Share EffectiveIssuePricePerShare	9.35
	kvac	Percentage Of Aggregate Gross Proceeds PercentageOfAggregateGrossProceeds	0.60	pure
CY2023Q3	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	9.35
CY2023Q3	kvac	Percentage Of Exercise Price Warrants PercentageOfExercisePriceWarrants	1.15	pure
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	16.5
	kvac	Percentage Of Market Value PercentageOfMarketValue	1.65	pure
	us-gaap	Underwriting Expense Ratio UnderwritingExpenseRatio	0.02	pure
	kvac	Gross Proceeds From Issuance Of Initial Public Offering GrossProceedsFromIssuanceOfInitialPublicOffering	2990000	usd
CY2023Q3	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent		usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock		usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend		usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend		usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Hybrid Instrument Net UnrealizedGainLossOnHybridInstrumentNet		usd
	us-gaap	Unrealized Gain Loss On Hybrid Instrument Net UnrealizedGainLossOnHybridInstrumentNet		usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	kvac	Initial Classification Of Common Stock Subject To Possible Redemption InitialClassificationOfCommonStockSubjectToPossibleRedemption		usd
	kvac	Allocation Of Offering Costs To Common Stock Subject To Possible Redemption AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption		usd
	kvac	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue		usd
	kvac	Accrued Underwriting Compensation AccruedUnderwritingCompensation		usd
	kvac	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue		usd
CY2022Q3	kvac	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001889983

Files In Submission

Name	View Source	Status
kvac-20230930_cal.xml	Edgar Link	unprocessable
0001213900-23-086916-index-headers.html	Edgar Link	pending
0001213900-23-086916-index.html	Edgar Link	pending
0001213900-23-086916.txt	Edgar Link	pending
0001213900-23-086916-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_keenvision.htm	Edgar Link	pending
f10q0923ex31-2_keenvision.htm	Edgar Link	pending
f10q0923ex32-1_keenvision.htm	Edgar Link	pending
f10q0923ex32-2_keenvision.htm	Edgar Link	pending
f10q0923_keenvision.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kvac-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kvac-20230930_lab.xml	Edgar Link	unprocessable
kvac-20230930_def.xml	Edgar Link	unprocessable
kvac-20230930_pre.xml	Edgar Link	unprocessable
f10q0923_keenvision_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KVAC
Keen Vision Acquisition Corp Stock $kvac

2023 Q4 Form 10-Q Financial Statement

#000121390023086916 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KVAC Keen Vision Acquisition Corp Stock $kvac

2023 Q4 Form 10-Q Financial Statement

#000121390023086916 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KVAC
Keen Vision Acquisition Corp Stock $kvac